Detolid's explanation of the profit change; Increasing the rate of sales and changing the basket of products in the spotlight In explaining the change in the profit for the financial period ending on 31 Sha'ribar 1405 compared to the unaudited financial statements, the pharmaceutical company that produces the drug with the symbol "Detolide" announced two main factors: an increase in the rate of sales of the products and a change in the product portfolio.